AURUM BIOTECH LLP

In their own words

We specialize in sourcing and supplying pharmaceutical APIs (Active Pharmaceutical Ingredients) and intermediates, bridging the gap between bulk manufacturers and end-users such as pharmaceutical manufacturers and traders. Our unique business model focuses on purchasing in large quantities and distributing in optimal amounts, solving critical challenges for our customers such as: 1. Cost Efficiency for Customers – Bulk procurement directly from large manufacturers requires significant capital investment. By purchasing in bulk on behalf of multiple clients, we help them save costs without compromising on supply. 2. Minimized Product Wastage – APIs and intermediates have a fixed shelf life. Manufacturers often struggle with purchasing the right quantity, risking excess stock that expires before use. Our supply model eliminates this risk, ensuring they only buy what they need. 3. Optimized Supply Chain – We streamline the supply process by acting as a reliable intermediary, reducing lead times and ensuring consistent availability of raw materials. This allows pharmaceutical manufacturers to focus on production rather than procurement challenges. 4. Scalable Business Model – The pharmaceutical industry is expanding, with increasing demand for APIs and intermediates. Our model is highly scalable, with opportunities to grow into new markets, expand product offerings, and enhance our distribution network.

Written by the company on its public Startup India profile. Not verified by us.